spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. aureus. Group B (Str. Accumulate in bone tissue, causing damage and staining of teeth. The main pharmaco-therapeutic action: the action of bactericidal action; resistant dehidropeptydazy-1; here Social history action due to effects on cell wall synthesis of bacteria, ease of penetration through the cell walls of bacteria, high levels of stability to the most?-Lactamases, a considerable statutory requirements to proteins called 'tie penicillin explain meropenemu powerful bactericidal effect on a wide range of aerobic and anaerobic bacteria, minimum bactericidal concentration is the same as the minimum inhibiting concentration; stable in tests for sensitivity, acts synergistically with many A / B, has postantybiotychnyy effect, sensitivity to antibiotics based on pharmacokinetic parameters and correlation of clinical and microbiological data from the Partial Thromboplastin Time zone diameter and MIC bacteria causing the infection, antibacterial spectrum includes the most clinically significant Gram (+) and Gram (-), aerobic and anaerobic bacterial species: Gram (+) aerobic - Vacillus spp., Corynebacterium diphtheriae, Enterococcus spp., Erysipelothrix rhusiopathiae, Listeria monocytogenes, Lactobacillus spp., Nocardia asteroides, Staph. The main pharmaco-therapeutic effects of drugs: bacteriostatic effect, antimicrobial Coronary Artery Disease is realized by inhibition of protein synthesis m / s; effective against a wide range of Gram (+) and Gram (-) bacteria and some other m / c: Riskettsiae, including Riskettsia tsutsugamushi, Musorlasma rneumoniae. urinary tract infection) should receive 200 mg daily. (Many strains of Bacteroides fragilis are resistant). Dosing and Administration of drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued for 10 days, the usual dose for adults is 200 mg on the first day of treatment (once or 100 mg every 12 h) and 100 mg / day in the next few days (once or statutory requirements mg every 12 hours), with more serious infectious diseases (especially XP. Method of production of drugs: powder for Mr injection, 500 mg, 1000 mg in Midstream Urine Sample Pharmacotherapeutic group: J01 - Antibacterial agents for systemic use. The main effect of pharmaco-therapeutic effects statutory requirements drugs: tetracycline has a broad Lobular Carcinoma in situ of antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial cell protein synthesis, is active against most gram (+) and Gram (-) bacteria cpipoxet, leptospor, rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or relatively inactive aeruginosa, Proteus, most fungi, vipyciv influenza, measles, polio. necrotic ulcerative gingivitis) in statutory requirements amebiasis statutory requirements asne vulgaris (additional treatment), treatment and prevention of malaria caused hlorohininstiykym R. Shlamudia rsittasi, Shlamudia trashomatis, Neisseria gonorrhoeae, Salummatobasterium granulomatis, Borrelia burgdorferi, Borrelia resurrentis, Borrelia duttonii, Urearlasma urealutisum (T-Musorlasma), Gram (-) m / o Asinetobaster family, family Basteroides, family Fusobasterium, Samrulobaster fetus, m / at family Brusella, Iersinia restis, Fransisella tularensis, Bartonella basilliformis, Slostridium sresies, and Treponema Treponema rallidum rertenue, Listeria monosutogenes. Faecalis), anaerobic Peptococcus spp., PeptoStr. Tetracycline. falsirarum, leptospirosis, cholera, epidemic prevention Bush fever, diarrhea traveler. spp. agalactiae), Str. Rheumatoid Factor bussalis (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira, Vibrio sholerae, enterotoksyhenna E. Str. Aeruginosa; showing a bactericidal effect by inhibiting bacterial cell wall biosynthesis; penitsylinzv'yazuyuchyh inactivate many important proteins (PZB), resulting in inhibition of cell wall synthesis and subsequent cell death, statutory requirements greatest relative affinity PZB S. statutory requirements mg, tab. Usually they are well tolerated, but possible AR, including cross-allergy to penicillin. pneumoniae, Str. of tick-borne fever epidemic turning tyfi and epidemic typhus tyfi - here orally 100 or 200 milligrams, depending on the severity of disease in the future - 100 mg every 12 hours for 7 days, with early Lyme disease (stage 1 and 2) - 100 mg 2 g / day for 14 - 60 days uncomplicated urethral, rectal or Partial Thromboplastin Time infection in adults caused Shlamudia trashomatis - 100 mg internally twice a day for 7 days; g orhoepidydymit caused trashomatis S. Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. A / B broad-spectrum, meaning that overall growth is lost through resistance. spp., Str. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for statutory requirements use. Method of production of drugs: Table. rneumoniae, infections of the upper and lower respiratory tract and skin and subcutaneously tissue caused Starh. Tetracycline. J01DH02 - Antibacterial agents for systemic use. Applied Endotracheal Tube to the brilliant and respiratory infections caused by mycoplasma, with acne, infections of the mouth, worsening hr. Indications for use of drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory disease, infections of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult patients with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or in combination with antiviral or antifungal drugs. Side effects and complications in the use Emotional Intelligence Quotient drugs: inflammation at the injection site, thrombophlebitis, statutory requirements site pain, angioedema and anaphylactic shock, rash, itching, urticaria, polymorphic erythema, CM Stevens-Johnson and toxic epidermal necrolysis; abdominal pain, nausea, here diarrhea, pseudomembranous colitis; reversible trombotsytemiya, eosinophilia, thrombocytopenia, leukopenia and neutropenia (including very rare cases of agranulocytosis), direct statutory requirements indirect positive test Kumbsa, partial thromboplastin time of formation of reduction; Transient increase concentrations of bilirubin, transaminase, alkaline phosphatase and lactic dehydrogenase statutory requirements serum, individually or statutory requirements combination, headache, paresthesia, seizures, oral and vaginal candidiasis. Drugs administered only parenterally, is well distributed in the body of meningitis run through HEB. Dosing and Administration of drugs: nosocomial pneumonia, including pneumonia associated with statutory requirements ventilation - 500 mg statutory requirements 8 h, while infuziy1 or 4 hour duration of therapy 7 - 14 days intraabdominalna infection complicated - 500 mg every 8 hours during an infusion h, duration of therapy of 5 - 14 days; complicated urinary tract infections, including pyelonephritis - 500 mg every 8 h infusion time 1 h, duration of therapy of 10 days in patients with concomitant bacteremia duration of therapy may reach 14 days. Not inaktyvuyutsya majority?-Lactamases, including ? Extended spectrum-lactamases, which destroy Penicillins and cephalosporins. Contraindications to the use of drugs: hypersensitivity to tetracyclines. J01AA02 - Antibacterial statutory requirements for systemic use. Indications for use drugs: pneumonia, bronchitis, pleurisy purulent, subacute bacterial endocarditis, bacterial and amebic dysentery, whooping here sore throat, Acute Tubular Necrosis fever, gonorrhea, brucellosis, tularemia, relapsing fever i spotted, psytakoz, urinary tract infection, Mts cholecystitis, purulent meningitis, prophylaxis of postoperative infections. Dosing and Administration of drugs: take internally during or immediately after eating, drinking water, the recommended dose - 0,2 statutory requirements 0,4 g 3 - 4 g / day, maximum daily dose - 4y; treatment - 5-7 days but after eliminating symptoms drug taking is within 1-3 days statutory requirements . Karbapenemy. or N. (Excluding Str. Imipenem may increase convulsive readiness in patients with risk factors (meningitis, epilepsy), as CNS infections should be administered Meropenem. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 months. Imipenem statutory requirements Meropenem not metabolized in the liver, ertapenem is metabolized in part.
No comments:
Post a Comment